ACE: a probabilistic model for characterizing gene-level essentiality in CRISPR screens.

Area of Science:

• Genomics
• Cancer Biology
• Bioinformatics

Background:

• CRISPR-Cas9 knockout screens are essential for cancer gene discovery.
• Existing methods often overlook variations in screening data.
• Accurate identification of essential genes is crucial for targeted therapies.

Purpose of the Study:

• Introduce a probabilistic modeling framework, Analysis of CRISPR-based Essentiality (ACE).
• Enhance the statistical power and accuracy of CRISPR-Cas9 screen analysis.
• Identify novel genotype-specific essential genes and therapeutic targets.

Main Methods:

• Developed the ACE probabilistic modeling framework.
• Incorporated multiple sources of variation inherent in CRISPR-Cas9 screens.
• Validated ACE using simulations and analysis of public cancer genomics data.

Main Results:

• ACE effectively predicts both absolute and differential gene essentiality.
• Identified known and novel candidate genes for genotype-specific essentiality.
• Discovered enhanced essentiality of RNA m6-A methyltransferases in TP53-mutated cancers.

Conclusions:

• ACE offers a robust framework for analyzing CRISPR-Cas9 screen data.
• Enables new statistical tests for improved gene essentiality detection.
• Facilitates identification of genes for subtype-specific therapeutic targeting in cancer.